カテゴリー： LP Information, 世界, 部品/材料

世界のエンサルティニブ市場予測 2023年-2029年

◆英語タイトル：Global Ensartinib Market Growth 2023-2029
	◆商品コード：LP23JU3737 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：101 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥549,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥823,500	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,098,000	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のエンサルティニブ市場」は、過去の販売実績から2022年の世界のエンサルティニブの総販売量を検討し、2023年から2029年の予測されるエンサルティニブの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のエンサルティニブの市場規模を掲載し、XXX百万米ドル規模の世界のエンサルティニブ市場の詳細な分析を提供します。本インサイトレポートは、世界のエンサルティニブ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のエンサルティニブ市場における各社の独自のポジションをより深く理解するために、エンサルティニブ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のエンサルティニブ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。エンサルティニブの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。エンサルティニブの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。エンサルティニブのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

エンサルティニブの世界主要メーカーとしては、BioVision、 Cayman Chemical、 LifeSpan BioSciences、 Selleck Chemicals、 AbMole、 Biorbyt、 LKT Laboratories、 BOC Sciences、 Target Molecule、 MuseChem、 Wuhan Sun-Shine Bio-Technologyなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のエンサルティニブ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではエンサルティニブ市場をセグメンテーションし、種類別 (純度98%以下、純度98%～99%、純度99%以上)、用途別 (研究、医療)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度98%以下、純度98%～99%、純度99%以上

・用途別区分：研究、医療

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のエンサルティニブ市場の10年間の市場状況・展望は？
・世界および地域別に見たエンサルティニブ市場成長の要因は何か？
・エンサルティニブの市場機会はエンドマーケットの規模によってどのように変化するのか？
・エンサルティニブのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：エンサルティニブの年間販売量2018-2029、地域別現状・将来分析
・エンサルティニブの種類別セグメント：純度98%以下、純度98%～99%、純度99%以上
・エンサルティニブの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・エンサルティニブの用途別セグメント：研究、医療
・エンサルティニブの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のエンサルティニブ市場
・企業別のグローバルエンサルティニブ市場データ：2018-2023年の年間販売量、市場シェア
・企業別のエンサルティニブの年間売上：2018-2023年の売上、市場シェア
・企業別のエンサルティニブ販売価格
・主要企業のエンサルティニブ生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

エンサルティニブの地域別レビュー
・地域別のエンサルティニブ市場規模2018-2023：年間販売量、売上
・主要国別のエンサルティニブ市場規模2018-2023：年間販売量、売上
・南北アメリカのエンサルティニブ販売の成長
・アジア太平洋のエンサルティニブ販売の成長
・ヨーロッパのエンサルティニブ販売の成長
・中東・アフリカのエンサルティニブ販売の成長

南北アメリカ市場
・南北アメリカの国別のエンサルティニブ販売量、売上（2018-2023）
・南北アメリカのエンサルティニブの種類別販売量
・南北アメリカのエンサルティニブの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のエンサルティニブ販売量、売上（2018-2023）
・アジア太平洋のエンサルティニブの種類別販売量
・アジア太平洋のエンサルティニブの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のエンサルティニブ販売量、売上（2018-2023）
・ヨーロッパのエンサルティニブの種類別販売量
・ヨーロッパのエンサルティニブの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のエンサルティニブ販売量、売上（2018-2023）
・中東・アフリカのエンサルティニブの種類別販売量
・中東・アフリカのエンサルティニブの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・エンサルティニブの製造コスト構造分析
・エンサルティニブの製造プロセス分析
・エンサルティニブの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・エンサルティニブの主要なグローバル販売業者
・エンサルティニブの主要なグローバル顧客

地域別のエンサルティニブ市場予測レビュー
・地域別のエンサルティニブ市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・エンサルティニブの種類別市場規模予測
・エンサルティニブの用途別市場規模予測

主要企業分析
BioVision、 Cayman Chemical、 LifeSpan BioSciences、 Selleck Chemicals、 AbMole、 Biorbyt、 LKT Laboratories、 BOC Sciences、 Target Molecule、 MuseChem、 Wuhan Sun-Shine Bio-Technology
・企業情報
・エンサルティニブ製品
・エンサルティニブ販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity.
LPI (LP Information)’ newest research report, the “Ensartinib Industry Forecast” looks at past sales and reviews total world Ensartinib sales in 2022, providing a comprehensive analysis by region and market sector of projected Ensartinib sales for 2023 through 2029. With Ensartinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ensartinib industry.
This Insight Report provides a comprehensive analysis of the global Ensartinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ensartinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ensartinib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ensartinib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ensartinib.
The global Ensartinib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Ensartinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Ensartinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Ensartinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Ensartinib players cover BioVision, Cayman Chemical, LifeSpan BioSciences, Selleck Chemicals, AbMole, Biorbyt, LKT Laboratories, BOC Sciences and Target Molecule, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Ensartinib market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segmentation by application
Research
Medical
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
BioVision
Cayman Chemical
LifeSpan BioSciences
Selleck Chemicals
AbMole
Biorbyt
LKT Laboratories
BOC Sciences
Target Molecule
MuseChem
Wuhan Sun-Shine Bio-Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ensartinib market?
What factors are driving Ensartinib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ensartinib market opportunities vary by end market size?
How does Ensartinib break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ensartinib Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Ensartinib by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Ensartinib by Country/Region, 2018, 2022 & 2029
2.2 Ensartinib Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Ensartinib Sales by Type
2.3.1 Global Ensartinib Sales Market Share by Type (2018-2023)
2.3.2 Global Ensartinib Revenue and Market Share by Type (2018-2023)
2.3.3 Global Ensartinib Sale Price by Type (2018-2023)
2.4 Ensartinib Segment by Application
2.4.1 Research
2.4.2 Medical
2.5 Ensartinib Sales by Application
2.5.1 Global Ensartinib Sale Market Share by Application (2018-2023)
2.5.2 Global Ensartinib Revenue and Market Share by Application (2018-2023)
2.5.3 Global Ensartinib Sale Price by Application (2018-2023)
3 Global Ensartinib by Company
3.1 Global Ensartinib Breakdown Data by Company
3.1.1 Global Ensartinib Annual Sales by Company (2018-2023)
3.1.2 Global Ensartinib Sales Market Share by Company (2018-2023)
3.2 Global Ensartinib Annual Revenue by Company (2018-2023)
3.2.1 Global Ensartinib Revenue by Company (2018-2023)
3.2.2 Global Ensartinib Revenue Market Share by Company (2018-2023)
3.3 Global Ensartinib Sale Price by Company
3.4 Key Manufacturers Ensartinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ensartinib Product Location Distribution
3.4.2 Players Ensartinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ensartinib by Geographic Region
4.1 World Historic Ensartinib Market Size by Geographic Region (2018-2023)
4.1.1 Global Ensartinib Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Ensartinib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Ensartinib Market Size by Country/Region (2018-2023)
4.2.1 Global Ensartinib Annual Sales by Country/Region (2018-2023)
4.2.2 Global Ensartinib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Ensartinib Sales Growth
4.4 APAC Ensartinib Sales Growth
4.5 Europe Ensartinib Sales Growth
4.6 Middle East & Africa Ensartinib Sales Growth
5 Americas
5.1 Americas Ensartinib Sales by Country
5.1.1 Americas Ensartinib Sales by Country (2018-2023)
5.1.2 Americas Ensartinib Revenue by Country (2018-2023)
5.2 Americas Ensartinib Sales by Type
5.3 Americas Ensartinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ensartinib Sales by Region
6.1.1 APAC Ensartinib Sales by Region (2018-2023)
6.1.2 APAC Ensartinib Revenue by Region (2018-2023)
6.2 APAC Ensartinib Sales by Type
6.3 APAC Ensartinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ensartinib by Country
7.1.1 Europe Ensartinib Sales by Country (2018-2023)
7.1.2 Europe Ensartinib Revenue by Country (2018-2023)
7.2 Europe Ensartinib Sales by Type
7.3 Europe Ensartinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ensartinib by Country
8.1.1 Middle East & Africa Ensartinib Sales by Country (2018-2023)
8.1.2 Middle East & Africa Ensartinib Revenue by Country (2018-2023)
8.2 Middle East & Africa Ensartinib Sales by Type
8.3 Middle East & Africa Ensartinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ensartinib
10.3 Manufacturing Process Analysis of Ensartinib
10.4 Industry Chain Structure of Ensartinib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ensartinib Distributors
11.3 Ensartinib Customer
12 World Forecast Review for Ensartinib by Geographic Region
12.1 Global Ensartinib Market Size Forecast by Region
12.1.1 Global Ensartinib Forecast by Region (2024-2029)
12.1.2 Global Ensartinib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ensartinib Forecast by Type
12.7 Global Ensartinib Forecast by Application
13 Key Players Analysis
13.1 BioVision
13.1.1 BioVision Company Information
13.1.2 BioVision Ensartinib Product Portfolios and Specifications
13.1.3 BioVision Ensartinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BioVision Main Business Overview
13.1.5 BioVision Latest Developments
13.2 Cayman Chemical
13.2.1 Cayman Chemical Company Information
13.2.2 Cayman Chemical Ensartinib Product Portfolios and Specifications
13.2.3 Cayman Chemical Ensartinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cayman Chemical Main Business Overview
13.2.5 Cayman Chemical Latest Developments
13.3 LifeSpan BioSciences
13.3.1 LifeSpan BioSciences Company Information
13.3.2 LifeSpan BioSciences Ensartinib Product Portfolios and Specifications
13.3.3 LifeSpan BioSciences Ensartinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 LifeSpan BioSciences Main Business Overview
13.3.5 LifeSpan BioSciences Latest Developments
13.4 Selleck Chemicals
13.4.1 Selleck Chemicals Company Information
13.4.2 Selleck Chemicals Ensartinib Product Portfolios and Specifications
13.4.3 Selleck Chemicals Ensartinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Selleck Chemicals Main Business Overview
13.4.5 Selleck Chemicals Latest Developments
13.5 AbMole
13.5.1 AbMole Company Information
13.5.2 AbMole Ensartinib Product Portfolios and Specifications
13.5.3 AbMole Ensartinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AbMole Main Business Overview
13.5.5 AbMole Latest Developments
13.6 Biorbyt
13.6.1 Biorbyt Company Information
13.6.2 Biorbyt Ensartinib Product Portfolios and Specifications
13.6.3 Biorbyt Ensartinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Biorbyt Main Business Overview
13.6.5 Biorbyt Latest Developments
13.7 LKT Laboratories
13.7.1 LKT Laboratories Company Information
13.7.2 LKT Laboratories Ensartinib Product Portfolios and Specifications
13.7.3 LKT Laboratories Ensartinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 LKT Laboratories Main Business Overview
13.7.5 LKT Laboratories Latest Developments
13.8 BOC Sciences
13.8.1 BOC Sciences Company Information
13.8.2 BOC Sciences Ensartinib Product Portfolios and Specifications
13.8.3 BOC Sciences Ensartinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 BOC Sciences Main Business Overview
13.8.5 BOC Sciences Latest Developments
13.9 Target Molecule
13.9.1 Target Molecule Company Information
13.9.2 Target Molecule Ensartinib Product Portfolios and Specifications
13.9.3 Target Molecule Ensartinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Target Molecule Main Business Overview
13.9.5 Target Molecule Latest Developments
13.10 MuseChem
13.10.1 MuseChem Company Information
13.10.2 MuseChem Ensartinib Product Portfolios and Specifications
13.10.3 MuseChem Ensartinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 MuseChem Main Business Overview
13.10.5 MuseChem Latest Developments
13.11 Wuhan Sun-Shine Bio-Technology
13.11.1 Wuhan Sun-Shine Bio-Technology Company Information
13.11.2 Wuhan Sun-Shine Bio-Technology Ensartinib Product Portfolios and Specifications
13.11.3 Wuhan Sun-Shine Bio-Technology Ensartinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Wuhan Sun-Shine Bio-Technology Main Business Overview
13.11.5 Wuhan Sun-Shine Bio-Technology Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Ensartinib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Ensartinib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Ensartinib Sales by Type (2018-2023) & (Kg)
Table 7. Global Ensartinib Sales Market Share by Type (2018-2023)
Table 8. Global Ensartinib Revenue by Type (2018-2023) & ($ million)
Table 9. Global Ensartinib Revenue Market Share by Type (2018-2023)
Table 10. Global Ensartinib Sale Price by Type (2018-2023) & (K USD/Kg)
Table 11. Global Ensartinib Sales by Application (2018-2023) & (Kg)
Table 12. Global Ensartinib Sales Market Share by Application (2018-2023)
Table 13. Global Ensartinib Revenue by Application (2018-2023)
Table 14. Global Ensartinib Revenue Market Share by Application (2018-2023)
Table 15. Global Ensartinib Sale Price by Application (2018-2023) & (K USD/Kg)
Table 16. Global Ensartinib Sales by Company (2018-2023) & (Kg)
Table 17. Global Ensartinib Sales Market Share by Company (2018-2023)
Table 18. Global Ensartinib Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Ensartinib Revenue Market Share by Company (2018-2023)
Table 20. Global Ensartinib Sale Price by Company (2018-2023) & (K USD/Kg)
Table 21. Key Manufacturers Ensartinib Producing Area Distribution and Sales Area
Table 22. Players Ensartinib Products Offered
Table 23. Ensartinib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Ensartinib Sales by Geographic Region (2018-2023) & (Kg)
Table 27. Global Ensartinib Sales Market Share Geographic Region (2018-2023)
Table 28. Global Ensartinib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Ensartinib Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Ensartinib Sales by Country/Region (2018-2023) & (Kg)
Table 31. Global Ensartinib Sales Market Share by Country/Region (2018-2023)
Table 32. Global Ensartinib Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Ensartinib Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Ensartinib Sales by Country (2018-2023) & (Kg)
Table 35. Americas Ensartinib Sales Market Share by Country (2018-2023)
Table 36. Americas Ensartinib Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Ensartinib Revenue Market Share by Country (2018-2023)
Table 38. Americas Ensartinib Sales by Type (2018-2023) & (Kg)
Table 39. Americas Ensartinib Sales by Application (2018-2023) & (Kg)
Table 40. APAC Ensartinib Sales by Region (2018-2023) & (Kg)
Table 41. APAC Ensartinib Sales Market Share by Region (2018-2023)
Table 42. APAC Ensartinib Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Ensartinib Revenue Market Share by Region (2018-2023)
Table 44. APAC Ensartinib Sales by Type (2018-2023) & (Kg)
Table 45. APAC Ensartinib Sales by Application (2018-2023) & (Kg)
Table 46. Europe Ensartinib Sales by Country (2018-2023) & (Kg)
Table 47. Europe Ensartinib Sales Market Share by Country (2018-2023)
Table 48. Europe Ensartinib Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Ensartinib Revenue Market Share by Country (2018-2023)
Table 50. Europe Ensartinib Sales by Type (2018-2023) & (Kg)
Table 51. Europe Ensartinib Sales by Application (2018-2023) & (Kg)
Table 52. Middle East & Africa Ensartinib Sales by Country (2018-2023) & (Kg)
Table 53. Middle East & Africa Ensartinib Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Ensartinib Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Ensartinib Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Ensartinib Sales by Type (2018-2023) & (Kg)
Table 57. Middle East & Africa Ensartinib Sales by Application (2018-2023) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Ensartinib
Table 59. Key Market Challenges & Risks of Ensartinib
Table 60. Key Industry Trends of Ensartinib
Table 61. Ensartinib Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Ensartinib Distributors List
Table 64. Ensartinib Customer List
Table 65. Global Ensartinib Sales Forecast by Region (2024-2029) & (Kg)
Table 66. Global Ensartinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Ensartinib Sales Forecast by Country (2024-2029) & (Kg)
Table 68. Americas Ensartinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Ensartinib Sales Forecast by Region (2024-2029) & (Kg)
Table 70. APAC Ensartinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Ensartinib Sales Forecast by Country (2024-2029) & (Kg)
Table 72. Europe Ensartinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Ensartinib Sales Forecast by Country (2024-2029) & (Kg)
Table 74. Middle East & Africa Ensartinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Ensartinib Sales Forecast by Type (2024-2029) & (Kg)
Table 76. Global Ensartinib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Ensartinib Sales Forecast by Application (2024-2029) & (Kg)
Table 78. Global Ensartinib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. BioVision Basic Information, Ensartinib Manufacturing Base, Sales Area and Its Competitors
Table 80. BioVision Ensartinib Product Portfolios and Specifications
Table 81. BioVision Ensartinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 82. BioVision Main Business
Table 83. BioVision Latest Developments
Table 84. Cayman Chemical Basic Information, Ensartinib Manufacturing Base, Sales Area and Its Competitors
Table 85. Cayman Chemical Ensartinib Product Portfolios and Specifications
Table 86. Cayman Chemical Ensartinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 87. Cayman Chemical Main Business
Table 88. Cayman Chemical Latest Developments
Table 89. LifeSpan BioSciences Basic Information, Ensartinib Manufacturing Base, Sales Area and Its Competitors
Table 90. LifeSpan BioSciences Ensartinib Product Portfolios and Specifications
Table 91. LifeSpan BioSciences Ensartinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 92. LifeSpan BioSciences Main Business
Table 93. LifeSpan BioSciences Latest Developments
Table 94. Selleck Chemicals Basic Information, Ensartinib Manufacturing Base, Sales Area and Its Competitors
Table 95. Selleck Chemicals Ensartinib Product Portfolios and Specifications
Table 96. Selleck Chemicals Ensartinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 97. Selleck Chemicals Main Business
Table 98. Selleck Chemicals Latest Developments
Table 99. AbMole Basic Information, Ensartinib Manufacturing Base, Sales Area and Its Competitors
Table 100. AbMole Ensartinib Product Portfolios and Specifications
Table 101. AbMole Ensartinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 102. AbMole Main Business
Table 103. AbMole Latest Developments
Table 104. Biorbyt Basic Information, Ensartinib Manufacturing Base, Sales Area and Its Competitors
Table 105. Biorbyt Ensartinib Product Portfolios and Specifications
Table 106. Biorbyt Ensartinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 107. Biorbyt Main Business
Table 108. Biorbyt Latest Developments
Table 109. LKT Laboratories Basic Information, Ensartinib Manufacturing Base, Sales Area and Its Competitors
Table 110. LKT Laboratories Ensartinib Product Portfolios and Specifications
Table 111. LKT Laboratories Ensartinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 112. LKT Laboratories Main Business
Table 113. LKT Laboratories Latest Developments
Table 114. BOC Sciences Basic Information, Ensartinib Manufacturing Base, Sales Area and Its Competitors
Table 115. BOC Sciences Ensartinib Product Portfolios and Specifications
Table 116. BOC Sciences Ensartinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 117. BOC Sciences Main Business
Table 118. BOC Sciences Latest Developments
Table 119. Target Molecule Basic Information, Ensartinib Manufacturing Base, Sales Area and Its Competitors
Table 120. Target Molecule Ensartinib Product Portfolios and Specifications
Table 121. Target Molecule Ensartinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 122. Target Molecule Main Business
Table 123. Target Molecule Latest Developments
Table 124. MuseChem Basic Information, Ensartinib Manufacturing Base, Sales Area and Its Competitors
Table 125. MuseChem Ensartinib Product Portfolios and Specifications
Table 126. MuseChem Ensartinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 127. MuseChem Main Business
Table 128. MuseChem Latest Developments
Table 129. Wuhan Sun-Shine Bio-Technology Basic Information, Ensartinib Manufacturing Base, Sales Area and Its Competitors
Table 130. Wuhan Sun-Shine Bio-Technology Ensartinib Product Portfolios and Specifications
Table 131. Wuhan Sun-Shine Bio-Technology Ensartinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 132. Wuhan Sun-Shine Bio-Technology Main Business
Table 133. Wuhan Sun-Shine Bio-Technology Latest Developments
List of Figures
Figure 1. Picture of Ensartinib
Figure 2. Ensartinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ensartinib Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Ensartinib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Ensartinib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Ensartinib Sales Market Share by Type in 2022
Figure 13. Global Ensartinib Revenue Market Share by Type (2018-2023)
Figure 14. Ensartinib Consumed in Research
Figure 15. Global Ensartinib Market: Research (2018-2023) & (Kg)
Figure 16. Ensartinib Consumed in Medical
Figure 17. Global Ensartinib Market: Medical (2018-2023) & (Kg)
Figure 18. Global Ensartinib Sales Market Share by Application (2022)
Figure 19. Global Ensartinib Revenue Market Share by Application in 2022
Figure 20. Ensartinib Sales Market by Company in 2022 (Kg)
Figure 21. Global Ensartinib Sales Market Share by Company in 2022
Figure 22. Ensartinib Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Ensartinib Revenue Market Share by Company in 2022
Figure 24. Global Ensartinib Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Ensartinib Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Ensartinib Sales 2018-2023 (Kg)
Figure 27. Americas Ensartinib Revenue 2018-2023 ($ Millions)
Figure 28. APAC Ensartinib Sales 2018-2023 (Kg)
Figure 29. APAC Ensartinib Revenue 2018-2023 ($ Millions)
Figure 30. Europe Ensartinib Sales 2018-2023 (Kg)
Figure 31. Europe Ensartinib Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Ensartinib Sales 2018-2023 (Kg)
Figure 33. Middle East & Africa Ensartinib Revenue 2018-2023 ($ Millions)
Figure 34. Americas Ensartinib Sales Market Share by Country in 2022
Figure 35. Americas Ensartinib Revenue Market Share by Country in 2022
Figure 36. Americas Ensartinib Sales Market Share by Type (2018-2023)
Figure 37. Americas Ensartinib Sales Market Share by Application (2018-2023)
Figure 38. United States Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Ensartinib Sales Market Share by Region in 2022
Figure 43. APAC Ensartinib Revenue Market Share by Regions in 2022
Figure 44. APAC Ensartinib Sales Market Share by Type (2018-2023)
Figure 45. APAC Ensartinib Sales Market Share by Application (2018-2023)
Figure 46. China Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Ensartinib Sales Market Share by Country in 2022
Figure 54. Europe Ensartinib Revenue Market Share by Country in 2022
Figure 55. Europe Ensartinib Sales Market Share by Type (2018-2023)
Figure 56. Europe Ensartinib Sales Market Share by Application (2018-2023)
Figure 57. Germany Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Ensartinib Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Ensartinib Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Ensartinib Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Ensartinib Sales Market Share by Application (2018-2023)
Figure 66. Egypt Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Ensartinib Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Ensartinib in 2022
Figure 72. Manufacturing Process Analysis of Ensartinib
Figure 73. Industry Chain Structure of Ensartinib
Figure 74. Channels of Distribution
Figure 75. Global Ensartinib Sales Market Forecast by Region (2024-2029)
Figure 76. Global Ensartinib Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Ensartinib Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Ensartinib Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Ensartinib Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Ensartinib Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のエンサルティニブ市場予測 2023年-2029年(Global Ensartinib Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のエンサルティニブ市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp